| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| tarloxotinib | epidermal growth factor receptor | NA | Successful target | TTD , DGIDB | Non-Small Cell Lung Carcinoma[MeSHID:D002289] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.36 | phase 2 | inhibitor |
| tarloxotinib | erbb2 tyrosine kinase receptor | NA | Successful target | TTD | Non-Small Cell Lung Carcinoma[MeSHID:D002289] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | phase 2 | unknown |
| click here to return to the previous page | ||||||||